Eyevensys completes €7.5m Series A financing to develop EYS606
9 October 2015 | By Victoria White
The Company is developing EYS606, an innovative combination product associating a DNA plasmid encoding a therapeutic protein with an injection-electroporation device, for the treatment of Non-Infectious Posterior Uveitis...